Publication | Open Access
First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancer
37
Citations
18
References
2007
Year
The regimen has shown promising efficacy with manageable toxicity as a first-line treatment for patients with advanced CRC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1